Skip to ContentSkip to Navigation
About us Faculty of Science and Engineering Our Research GRIP Pharmaceutical Technology and Biopharmacy Output

2005

Requests for reprints can be addressed to:

Wouter Hinrichs

Bouwman AM, Henstra MJ, Westerman D, Chung JT, Zhang Z, Ingram A, Seville JPK, Frijlink HW

The effect of the amount of binder liquid on the granulation mechanisms and structure of microcrystalline cellulose granules prepared by high shear granulation

Int J Pharm, 290, 129-136, 2005

Bouwman AM, Henstra MJ, Hegge JJME, Zhang Z, Ingram A, Seville JPK, Frijlink HW

The relation between granule size, granule stickiness, and torque in the high-shear granulation process

Pharm Res, 22, 270-275, 2005

Dickhoff BHJ, de Boer AH, Lambregts D, Frijlink HW

The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation

Eur J Pharm Biopharm, 59, 197-205, 2005

 

de Boer AH, Dickhoff BHJ, Hagedoorn P, Gjaltema D, Goede J, Lambregts D, Frijlink HW

A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation

Int J Pharm, 294, 173-184, 2005

Frijlink HW, de Boer AH

Trends in the technology-driven development of new inhalation devices

Drug Discovery Today: Technologies, 1, 47-57, 2005

Hinrichs WLJ, Sanders NN, De Smedt SC, Demeester J, Frijlink HW

Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes

J Control Release, 103, 465-479, 2005

van Drooge DJ, Hinrichs WLJ, Dickhoff BHJ, Eli MNA, Visser MR, Zijlstra GS, Frijlink HW

Spray freeze drying to produce a stable ∆9-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation

Eur J Pharm Sci, 26, 231-240, 2005

Schellekens RCA, Stuurman FE, Frijlink HW, Kosterink JGW

Development of oral administration form with colon-specific release: New approach of the study on lactose intolerance

PW, 140 (11), 366-368, 2005

(pdf not available)

van Veen B, Pajander J, Zuurman K, Lappalainen R, Poso A, Frijlink HW, Ketolainen J

The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets

Eur J Pharm Biopharm, 61, 149-157, 2005

Veen B, Bolhuis GK, Wu YS, Zuurman K, Frijlink HW

Compaction mechanism and tablet strength of unlubricated and lubricated (silicified) microcrystalline cellulose

Eur J Pharm Biopharm, 59, 133-138, 2005

de Vegt O, Vromans H, Faassen F, van der Voort Maarschalk K

Milling of organic solids in a jet mill. Part 1: Determination of the selection function and related mechanical material properties

Part Part Syst Charact, 22, 133-140, 2005

de Vegt O, Vromans H, Faassen F, van der Voort Maarschalk K

Milling of organic solids in a jet mill. Part 2: Checking the validity of the predicted rate of breakage function

Part Part Syst Charact, 22, 261-267, 2005

van Waarde A, Maas B, Doze P, Slart RH, Frijlink HW, Vaalburg W, Elsinga PH

Positron emission tomography studies of human airways using an inhaled β-adrenoceptor antagonist, S-11 C-CGP 12388*

Chest, 128, 3020-3027, 2005

Wu YS, Frijlink HW, van Vliet LJ, Stokroos I, van der Voort Maarschalk K

Location-dependent analysis of porosity and pore direction in tablets

Pharm Res, 22( 8), 1399-1405, 2005

Laatst gewijzigd:10 januari 2020 08:02